🇺🇸 FDA
Patent

US 7423142

Compositions and methods for inhibiting expression of anti-apoptotic genes

granted A61PA61P1/18A61P31/00

Quick answer

US patent 7423142 (Compositions and methods for inhibiting expression of anti-apoptotic genes) held by Alnylam Pharmaceuticals, Inc. expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Alnylam Pharmaceuticals, Inc.
Grant date
Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/18, A61P31/00, A61P35/00